vs
Side-by-side financial comparison of Goosehead Insurance, Inc. (GSHD) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Goosehead Insurance, Inc. is the larger business by last-quarter revenue ($93.1M vs $57.6M, roughly 1.6× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 23.1%).
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
GSHD vs PHAT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $57.6M |
| Net Profit | $8.0M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 16.1% | — |
| Net Margin | 8.6% | — |
| Revenue YoY | 23.1% | 94.1% |
| Net Profit YoY | 204.0% | 71.6% |
| EPS (diluted) | $0.19 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $93.1M | — | ||
| Q4 25 | $105.3M | $57.6M | ||
| Q3 25 | $90.4M | $49.5M | ||
| Q2 25 | $94.0M | $39.5M | ||
| Q1 25 | $75.6M | $28.5M | ||
| Q4 24 | $93.9M | $29.7M | ||
| Q3 24 | $78.0M | $16.4M | ||
| Q2 24 | $78.1M | $7.3M |
| Q1 26 | $8.0M | — | ||
| Q4 25 | $12.4M | — | ||
| Q3 25 | $7.9M | $-30.0M | ||
| Q2 25 | $5.2M | $-75.8M | ||
| Q1 25 | $2.3M | $-94.3M | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $7.6M | $-85.6M | ||
| Q2 24 | $6.2M | $-91.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% |
| Q1 26 | 16.1% | — | ||
| Q4 25 | 29.4% | — | ||
| Q3 25 | 23.5% | -30.8% | ||
| Q2 25 | 16.7% | -151.7% | ||
| Q1 25 | 8.8% | -276.5% | ||
| Q4 24 | 29.7% | — | ||
| Q3 24 | 21.1% | -433.0% | ||
| Q2 24 | 19.7% | -1055.4% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 11.8% | — | ||
| Q3 25 | 8.7% | -60.5% | ||
| Q2 25 | 5.5% | -191.9% | ||
| Q1 25 | 3.1% | -330.7% | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | 9.7% | -523.3% | ||
| Q2 24 | 7.9% | -1248.6% |
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.48 | — | ||
| Q3 25 | $0.29 | $-0.41 | ||
| Q2 25 | $0.18 | $-1.05 | ||
| Q1 25 | $0.09 | $-1.31 | ||
| Q4 24 | $0.58 | — | ||
| Q3 24 | $0.29 | $-1.32 | ||
| Q2 24 | $0.24 | $-1.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.7M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $-121.3M | $-438.2M |
| Total Assets | $392.8M | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $25.7M | — | ||
| Q4 25 | $34.4M | $130.0M | ||
| Q3 25 | $51.6M | $135.2M | ||
| Q2 25 | $92.4M | $149.6M | ||
| Q1 25 | $70.2M | $212.3M | ||
| Q4 24 | $54.3M | $297.3M | ||
| Q3 24 | $47.5M | $334.7M | ||
| Q2 24 | $23.6M | $276.2M |
| Q1 26 | — | — | ||
| Q4 25 | $289.5M | $209.1M | ||
| Q3 25 | $290.0M | $207.1M | ||
| Q2 25 | $289.8M | $205.1M | ||
| Q1 25 | $290.3M | $203.2M | ||
| Q4 24 | $82.3M | $201.4M | ||
| Q3 24 | $84.6M | $175.7M | ||
| Q2 24 | $87.0M | $174.4M |
| Q1 26 | $-121.3M | — | ||
| Q4 25 | $-95.5M | $-438.2M | ||
| Q3 25 | $-105.0M | $-422.5M | ||
| Q2 25 | $-78.6M | $-405.8M | ||
| Q1 25 | $-88.5M | $-338.4M | ||
| Q4 24 | $43.9M | $-253.6M | ||
| Q3 24 | $58.3M | $-187.1M | ||
| Q2 24 | $39.8M | $-233.8M |
| Q1 26 | $392.8M | — | ||
| Q4 25 | $414.9M | $259.1M | ||
| Q3 25 | $403.6M | $240.3M | ||
| Q2 25 | $436.6M | $250.2M | ||
| Q1 25 | $412.6M | $294.2M | ||
| Q4 24 | $397.7M | $378.3M | ||
| Q3 24 | $358.1M | $387.0M | ||
| Q2 24 | $338.2M | $319.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.87× | — | ||
| Q3 24 | 1.45× | — | ||
| Q2 24 | 2.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-166.8M |
| Free Cash FlowOCF − Capex | — | $-167.0M |
| FCF MarginFCF / Revenue | — | -290.0% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $91.8M | $-166.8M | ||
| Q3 25 | $24.2M | $-14.1M | ||
| Q2 25 | $28.9M | $-62.7M | ||
| Q1 25 | $15.5M | $-84.9M | ||
| Q4 24 | $71.5M | $-266.8M | ||
| Q3 24 | $28.1M | $-63.6M | ||
| Q2 24 | $18.9M | $-70.7M |
| Q1 26 | — | — | ||
| Q4 25 | $86.1M | $-167.0M | ||
| Q3 25 | $23.7M | $-14.1M | ||
| Q2 25 | $27.2M | $-62.8M | ||
| Q1 25 | $14.9M | $-84.9M | ||
| Q4 24 | $70.6M | $-266.9M | ||
| Q3 24 | $28.0M | $-63.6M | ||
| Q2 24 | $18.6M | $-70.8M |
| Q1 26 | — | — | ||
| Q4 25 | 81.8% | -290.0% | ||
| Q3 25 | 26.2% | -28.6% | ||
| Q2 25 | 28.9% | -159.0% | ||
| Q1 25 | 19.7% | -297.9% | ||
| Q4 24 | 75.1% | -899.8% | ||
| Q3 24 | 35.9% | -389.0% | ||
| Q2 24 | 23.9% | -966.2% |
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 0.4% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 1.8% | 0.2% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.0% | 0.5% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.3% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 7.38× | — | ||
| Q3 25 | 3.06× | — | ||
| Q2 25 | 5.61× | — | ||
| Q1 25 | 6.61× | — | ||
| Q4 24 | 4.82× | — | ||
| Q3 24 | 3.72× | — | ||
| Q2 24 | 3.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
PHAT
Segment breakdown not available.
